Tuhura Biosciences Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.63

+0.19 (+42.95%)

As of Feb 8, 2:20 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 8 89%

Hold 1 11%

Sell 0 0%

Price Target

Analyst Price Target +2,111.4% upside

Low Target $12.64

Average Target $13.91

High Target $18.47

Current Price $0.63

Current
$0.63

Target
$13.91

$12.64 $13.91 avg $18.47

Scenario Analysis

Bear Case

$12.64

1,909.5%

Low target

Base Case

$13.91

+2,111.4%

Avg target

Bull Case

$18.47

+2,836.4%

High target

Risk/Reward

1.5x

Balanced

Price in Context

52-Week High

$17.92

-96.5% from high

52-Week Low

$10.83

+-94.2% from low

Target vs 52W High

$13.91

-22.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%